Jakob Benedict Seidelin

Jakob Benedict Seidelin

Clinical Professor

Member of:

  • Internal Medicine: Gastroenterology and Hepatology


  1. 2024
  2. E-pub ahead of print

    Predicting treatment response in ASUC: do we measure systemic severity, organ response or both?

    Ovesen, P. D., Ilvemark, J. F. K. F., Wilkens, R., Steenholdt, Casper & Seidelin, Jakob Benedict, 1 Apr 2024, (E-pub ahead of print) In: Gut. 2 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  3. Published

    Intestinal ultrasound in inflammatory bowel disease

    Bjerrum, Jakob Tveiten , Ilvemark, J., Seidelin, Jakob Benedict & Wilkens, R., 5 Feb 2024, In: Ugeskrift for Laeger. 186, 6

    Research output: Contribution to journalReviewResearchpeer-review

  4. Published

    Editorial: Time to address quality of life in our IBD treatment — IBD nurse intervention as a key part of multimodal IBD management

    Seidelin, Jakob Benedict, 2024, In: Alimentary Pharmacology and Therapeutics. 59, 9, p. 1152-1153

    Research output: Contribution to journalEditorialResearchpeer-review

  5. Published

    IAPs and RIPK1 mediate LPS-induced cytokine production in healthy subjects and Crohn's disease

    Seidelin, Jakob Benedict, Jensen, Simone, Hansen, M., Bronze, M. R. D. C., Cuchet-Lourenҫo, D., Nejentsev, S., LaCasse, E. C. & Nielsen, Ole Haagen, 2024, In: Clinical and Experimental Immunology. 215, 3, p. 291–301 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Accepted/In press

    Infant Ustekinumab Clearance, Risk of Infection, and Development After Exposure During Pregnancy

    Julsgaard, M., Wieringa, J. W., Baunwall, S. M. D., Bibby, B. M., Driessen, G. J. A., Kievit, L., Brodersen, J. B., Poulsen, A., Kjeldsen, J., Hansen, M. M., Tang, H. Q., Balmer, C. L., Glerup, H., Seidelin, J. B., Haderslev, K. V., Svenningsen, L., Wildt, S., Juel, M. A., Neumann, A., Fuglsang, J. & 31 others, Jess, T., Haase, A. M., Hvas, C. L., Kelsen, J., Janneke van der Woude, C., Korgaard, J., Vestergaard, T., Lystbæk, U. L., Berg, A., Mikkelsen, A. T., Holm, A. M., Hansen, A. B., Mathiesen, O., Jensen, J. K., Neumann, L., Boris, J., Lemming, M., Rahbek, M., Westergaard, H. B., Friis-Hansen, L. J., Møller, L. A., Søeby, K., Hilsted, L., Christiansen, L., Sharif, H., Langholz, Ebbe, Kamstrup, P. R., Jochumsen, A., Huusom, Lene Drasbek, Wilken-Jensen, C. & NEXUS Collaborator Group, N. C. G., 2024, (Accepted/In press) In: Clinical Gastroenterology and Hepatology. 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. E-pub ahead of print

    Peripheral joint and enthesis involvement in patients with newly diagnosed inflammatory bowel disease: symptoms, clinical and ultrasound findings - a population-based cohort study

    Vladimirova, N., Terslev, Lene, Attauabi, M., Madsen, G., Fana, V., Wiell, C., Døhn, U. M., Bendtsen, Flemming, Seidelin, Jakob Benedict, Burisch, J. & Østergaard, Mikkel, 2024, (E-pub ahead of print) In: Journal of Crohn's & colitis.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. 2023
  9. Published

    Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis—authors' reply

    Dahl, E. K., Abed, O. K., Kjeldsen, J., dqp123, dqp123, Svane, Inge Marie, Dige, A., Agnholt, J. S., Bjerrum, Jakob Tveiten & Seidelin, Jakob Benedict, Jan 2023, In: Alimentary Pharmacology and Therapeutics. 57, 1, p. 152-153 2 p.

    Research output: Contribution to journalEditorialResearchpeer-review

  10. Published

    Comparative onset of effect of biologics and small molecules in moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis

    Attauabi, M., Dahl, E. K., Burisch, J., Gubatan, J., Nielsen, Ole Haagen & Seidelin, Jakob Benedict, 2023, In: EClinicalMedicine. 57, 3, 101866.

    Research output: Contribution to journalReviewResearchpeer-review

  11. Published

    Disease Activity Patterns of Inflammatory Bowel Disease - A Danish Nationwide Cohort Study 1995-2018

    Wewer, M. D., Langholz, Ebbe, Munkholm, Pia, Bendtsen, Flemming, Seidelin, Jakob Benedict & Burisch, J., 2023, In: Journal of Crohn's & colitis. 17, 3, p. 329–337

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Distinct immune cell trigger responses in Ulcerative Colitis – Results from an in vivo human intestinal injury model

    Bronze, M., Johansen, Jens Vilstrup, Attauabi, M., Bjerrum, Jakob Tveiten , Ramírez Galera, Marina, Woetmann, Anders & Seidelin, Jakob Benedict, 2023, In: Journal of Crohn's and Colitis. 17, Supplement_1, p. i199-i200

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  13. Published

    Letter: be careful of gastrointestinal CMV infection in adverse event from ICIs therapy in solid tumours — Authors' reply

    Dahl, E., Abed, O., Agnholt, J., Bjerrum, Jakob Tveiten , Dige, A., Kjeldsen, J., Svane, Inge Marie, Donia, M. & Seidelin, Jakob Benedict, 2023, In: Alimentary Pharmacology and Therapeutics. 57, 8, p. 918-919

    Research output: Contribution to journalComment/debateResearchpeer-review

  14. Published

    Optimizing Screening for Colorectal Cancer: An Algorithm Combining Fecal Immunochemical Test, Blood-Based Cancer-Associated Proteins and Demographics to Reduce Colonoscopy Burden

    Petersen, M. M., Kleif, Jakob, Jørgensen, Lars Nannestad, Hendel, J. W., Seidelin, Jakob Benedict, Madsen, M. R., Vilandt, J., Brandsborg, S., Rasmussen, J. S., Andersen, L. M., Khalid, A., Ferm, L., Gawel, S. H., Martens, F., Andersen, B., Rasmussen, Morten, Davis, G. J., Christensen, I. J. & Therkildsen, C., 2023, In: Clinical Colorectal Cancer. 22, 2, p. 199-210 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Reply to comment on: "Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease - a systematic review with meta-analysis"

    Attauabi, M., Seidelin, Jakob Benedict & Burisch, J., 2023, In: Rendiconti di Gastro-Enterologia. 55, 2, p. 300-301

    Research output: Contribution to journalComment/debateResearchpeer-review

  16. Published

    Systematic Review with Meta-analysis: The Impact of Cancer Treatments on the Disease Activity of Inflammatory Bowel Diseases

    Grimsdottir, S., Attauabi, M., Kristine Dahl, E., Burisch, J. & Seidelin, Jakob Benedict, 2023, In: Journal of Crohn's and Colitis. 17, 7, p. 1139-1153 15 p.

    Research output: Contribution to journalReviewResearchpeer-review

  17. Published

    Tofacitinib for acute severe ulcerative colitis: a systematic review

    Steenholdt, Casper, Ovesen, P. D., Brynskov, J. & Seidelin, Jakob Benedict, 2023, In: Journal of Crohn's and Colitis. 17, 8, p. 1354-1363

    Research output: Contribution to journalReviewResearchpeer-review

  18. Published

    Unraveling the Place of Small Molecules in theTreatment of Fistulizing Crohn’s Disease—A Systematic Review and Network Meta-Analysis

    Attauabi, M., Rasmussen, D. N., Bergenheim, F. O., Burisch, J. & Seidelin, Jakob Benedict, 2023, In: Crohn's and Colitis 360. 5, 4, 2 p., otad074.

    Research output: Contribution to journalComment/debateResearchpeer-review

  19. 2022
  20. Published

    Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019 - A Population-based Study

    Attauabi, M., Dahlerup, J. F., Poulsen, A., Hansen, M. R., Vester-Andersen, Marianne Kajbæk, Prahm, A. P., Pedersen, N., Larsen, L., Jess, T., Neumann, A., Haderslev, K. V., Molazahi, A., Lødrup, A. B., Glerup, H., Oppfeldt, A. M., Jensen, M. D., Theede, K., Kiszka-Kanowitz, M., Seidelin, Jakob Benedict & Burisch, J., 2022, In: Inflammatory Bowel Diseases. 28, 10, p. 1618-1622

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    Defining transabdominal Intestinal Ultrasound treatment response and remission in Inflammatory Bowel Disease: Systematic review and expert consensus statement

    Ilvemark, J. F. K. F., Hansen, T., Goodsall, T. M., Seidelin, J. B., Al-Farhan, H., Allocca, M., Begun, J., Bryant, R. V., Carter, D., Christensen, B., Dubinsky, M. C., Gecse, K. B., Kucharzik, T., Lu, C., Maaser, C., Maconi, G., Nylund, K., Palmela, C., Wilson, S. R., Novak, K. & 1 others, Wilkens, R., 2022, In: Journal of Crohn's and Colitis. 16, 4, p. 554–580

    Research output: Contribution to journalReviewResearchpeer-review

  22. Published

    Early intestinal ultrasound predicts intravenous corticosteroid response in hospitalized patients with severe ulcerative colitis

    Ilvemark, J. F. K. F., Wilkens, R., Thielsen, P., Dige, A., Boysen, T., Brynskov, J., Bjerrum, Jakob Tveiten & Seidelin, Jakob Benedict, 2022, In: Journal of Crohn's & colitis. 16, 11, p. 1725–1734

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

    Peyrin-Biroulet, L., Hart, A., Bossuyt, P., Long, M., Allez, M., Juillerat, P., Armuzzi, A., Loftus, E. V., Ostad-Saffari, E., Scalori, A., Oh, Y. S., Tole, S., Chai, A., Pulley, J., Lacey, S., Sandborn, W. J., Aguilar, H., Ahmad, T., Akriviadis, E., Aldeguer Mante, X. & 31 others, Altorjay, I., Ananthakrishnan, A., Andersen, V., Andreu Garcia, M., Aumais, G., Avni-Biron, I., Axler, J., Ayub, K., Baert, F., Bafutto, M., Bamias, G., Bassan, I., Baum, C., Beaugerie, L., Behm, B., Bekal, P., Bennett, M., Bermejo San Jose, F., Bernstein, C., Bettenworth, D., Bhaskar, S., Biancone, L., Bilir, B., Blaeker, M., Bloom, S., Bohman, V., Bosques Padilla, F. J., Bouhnik, Y., Seidelin, Jakob Benedict, Staun, Michael & HICKORY Study Group, H. S. G., 2022, In: The Lancet Gastroenterology and Hepatology. 7, 2, p. 128-140 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study

    Vermeire, S. & LAUREL Study Group, L. S. G., 2022, In: The Lancet Gastroenterology and Hepatology. 7, 1, p. 28-37 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis

    Attauabi, M., Wewer, M. D., Bendtsen, Flemming, Seidelin, Jakob Benedict & Burisch, J., 2022, In: Inflammatory Bowel Diseases. 28, 11, p. 1756–1765

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Published

    Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study

    Attauabi, M., Madsen, G. R., Bendtsen, F., Wewer, A. V., Wilkens, R., Ilvemark, J., Vladimirova, N., Jensen, A. B., Jensen, F. K., Hansen, S. B., Siebner, H. R., Nielsen, Y. J. W., Møller, J. M., Thomsen, H. S., Thomsen, S. F., Ingels, H. A. S., Theede, K., Boysen, T., Bjerrum, J. T., Jakobsen, C. & 13 others, Dorn-Rasmussen, M., Jansson, S., Yao, Y., Burian, E. A., Møller, F. T., Fana, V., Wiell, C., Terslev, Lene, Østergaard, Mikkel, Bertl, K., Stavropoulos, A., Seidelin, Jakob Benedict & Burisch, J., 2022, In: BMJ Open. 12, 6, e055779.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published

    Lipidomic Trajectories Characterize Delayed Mucosal Wound Healing in Quiescent Ulcerative Colitis and Identify Potential Novel Therapeutic Targets

    Bjerrum, Jakob Tveiten , Wang, Y., Zhang, J., Riis, Lene Buhl, Nielsen, Ole Haagen & Seidelin, Jakob Benedict, 2022, In: International Journal of Biological Sciences. 18, 5, p. 1813-1828 16 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  28. Published

    Outcomes and long-term effects of COVID-19 in patients with inflammatory bowel diseases - a Danish prospective population-based cohort study with individual-level data

    Attauabi, M., Dahlerup, J. F., Poulsen, A., Hansen, M. R., Verner-Andersen, M. K., Eraslan, S., Prahm, A. P., Pedersen, N., Larsen, L., Jess, T., Neumann, A., Haderslev, K. V., Molazahi, A., Lødrup, A. B., Glerup, H., Oppfeldt, A. M., Jensen, M. D., Theede, K., Kiszka-Kanowitz, M., Seidelin, J. B. & 1 others, Burisch, J., 2022, In: Journal of Crohn's and Colitis. 16, 5, p. 757–767 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  29. Published

    Praktisk anvendelse af thiopuriner hos patienter med kronisk inflammatoriske tarmsygdomme

    Zhao, M., Wewer, M. D., Bjerrum, Jakob Tveiten , Steenholdt, Casper, Schiødt, Frank Vinholt, Haderslev, K., Kiszka-Kanowitz, M., Munkholm, Pia, Seidelin, Jakob Benedict & Burisch, J., 2022, In: Ugeskrift for Laeger. 184, 11, V09210706.

    Research output: Contribution to journalReviewResearchpeer-review

  30. Published

    Prediction of Relapse After Anti–Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies

    Pauwels, R. W. M., van der Woude, C. J., Nieboer, D., Steyerberg, E. W., Casanova, M. J., Gisbert, J. P., Kennedy, N. A., Lees, C. W., Louis, E., Molnár, T., Szántó, K., Leo, E., Bots, S., Downey, R., Lukas, M., Lin, W. C., Amiot, A., Lu, C., Roblin, X., Farkas, K. & 15 others, Seidelin, Jakob Benedict, Duijvestein, M., D'Haens, G. R., de Vries, A. C., Janneke van der Woude, C., Sleutjes, J. A. M., García-Ortiz, J. M., Brooks, A. J., Hamlin, P. J., Sebastian, S., Lobo, A. J., Dieleman, L. (. A., Ben-Horin, S., Steenholdt, Casper & CEASE Study Group, C. S. G., 2022, In: Clinical Gastroenterology and Hepatology. 20, 8, p. 1671-1686.e16

    Research output: Contribution to journalReviewResearchpeer-review

  31. Published

    Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor-induced colitis

    Dahl, E. K., Abed, O. K., Kjeldsen, J., dqp123, dqp123, Svane, Inge Marie, Dige, A., Agnholt, J. S., Bjerrum, Jakob Tveiten & Seidelin, Jakob Benedict, 2022, In: Alimentary Pharmacology and Therapeutics. 56, 9, p. 1370-1382 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  32. Published

    The effect of induced hyperammonaemia on sleep and melanopsin-mediated pupillary light response in patients with liver cirrhosis: A single-blinded randomized crossover trial

    Kann, A. E., Ba-Ali, S., Seidelin, Jakob Benedict, Larsen, F. S., Hamann, Steffen & Bjerring, Peter Nissen, 2022, In: PLoS ONE. 17, 9 , e0275067.

    Research output: Contribution to journalJournal articleResearchpeer-review

  33. Published

    Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report

    Holmstroem, R. B., Dahl, E. K., Helms, Morten, Nielsen, H. V., Andersen, J. B., Bjerrum, Jakob Tveiten , Svane, Inge Marie, Ellebaek, E. & Seidelin, Jakob Benedict, 2022, In: BMJ Open Gastroenterology. 9, 1, 4 p., e000989.

    Research output: Contribution to journalJournal articleResearchpeer-review

  34. Published

    Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review

    Démaris, A., Widigson, E. S. K., Ilvemark, J. F. K. F., Steenholdt, Casper, Seidelin, Jakob Benedict, Huisinga, W., Michelet, R., Aulin, L. B. S. & Kloft, C., 2022, In: Pharmaceutics. 14, 10, 2095.

    Research output: Contribution to journalReviewResearchpeer-review

  35. Published

    Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis

    Attauabi, M., Madsen, G. R., Bendtsen, Flemming, Seidelin, Jakob Benedict & Burisch, J., 2022, In: Digestive and Liver Disease. 54, 9, p. 1168-1178

    Research output: Contribution to journalReviewResearchpeer-review

  36. 2021
  37. Published

    Authors' Reply to: 'COVID-19 in the IBD Population: The Need for Correct Nomenclature'

    Attauabi, M., Seidelin, Jakob Benedict & Burisch, J., 22 Jun 2021, In: Journal of Crohn's & colitis. 15, 6, p. 1080 1 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  38. Published

    Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies – A Danish population-based cohort study

    Attauabi, M., Seidelin, Jakob Benedict, Felding, O. K., Wewer, M. D., Vinther Arp, L. K., Sarikaya, M. Z., Egeberg, A., Vladimirova, N., Bendtsen, Flemming & Burisch, J., Mar 2021, In: Journal of Autoimmunity. 118, 102613.

    Research output: Contribution to journalJournal articleResearchpeer-review

  39. Published

    Acute Experimental Barrier Injury Triggers Ulcerative Colitis–Specific Innate Hyperresponsiveness and Ulcerative Colitis–Type Microbiome Changes in Humans

    Seidelin, Jakob Benedict, Bahl, M. I., Licht, T. R., Mead, B. E., Karp, J. M., Johansen, Jens Vilstrup, Riis, Lene Buhl, Ramírez Galera, Marina, Woetmann, Anders & Bjerrum, Jakob Tveiten , 2021, In: Cellular and Molecular Gastroenterology and Hepatology. 12, 4, p. 1281-1296

    Research output: Contribution to journalJournal articleResearchpeer-review

  40. Published

    Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?

    Attauabi, M. & Danish COVID-IBD Study Group, D. C. S. G., 2021, In: Gut. 70, 10, p. 2020-2022

    Research output: Contribution to journalLetterResearchpeer-review

  41. Published

    CDX2 regulates interleukin-33 gene expression in intestinal epithelial cells (LS174T)

    Larsen, S., Seidelin, Jakob Benedict, Davidsen, J., Dahlgaard, K., Nielsen, Claus Henrik, Bennett, Eric Paul, Pedersen, O. B., Coskun, M. & Troelsen, J. T., 2021, In: FEBS Open Bio. 11, 6, p. 1638-1644

    Research output: Contribution to journalJournal articleResearchpeer-review

  42. Published

    Effectiveness of third-class biologic treatment in crohn’s disease: A multi-center retrospective cohort study

    Albshesh, A., Taylor, J., Savarino, E. V., Truyens, M., Armuzzi, A., Ribaldone, D. G., Shitrit, A. B. G., Fibelman, M., Molander, P., Liefferinckx, C., Nancey, S., Korani, M., Rutka, M., Acosta, M. B. D., Domislovic, V., Suris, G., Eriksson, C., Alves, C., Mpitouli, A., Di Jiang, C. & 26 others, Tepeš, K., Coletta, M., Foteinogiannopoulou, K., Gisbert, J. P., Amir-Barak, H., Attauabi, M., Seidelin, Jakob Benedict, Afif, W., Marinelli, C., Lobaton, T., Pugliese, D., Maharshak, N., Cremer, A., Limdi, J. K., Molnár, T., Otero-Alvarin, B., Krznaric, Z., Magro, F., Karmiris, K., Raine, T., Drobne, D., Koutroubakis, I., Chaparro, M., Yanai, H., Burisch, J. & Kopylov, U., 2021, In: Journal of Clinical Medicine. 10, 13, 2914.

    Research output: Contribution to journalJournal articleResearchpeer-review

  43. Published

    Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study

    Attauabi, M., Burisch, J. & Seidelin, Jakob Benedict, 2021, In: Inflammatory Bowel Diseases. 27, 3, p. e37-e38

    Research output: Contribution to journalComment/debateResearchpeer-review

  44. Published

    Efficacy of ustekinumab for active perianal fistulizing Crohn’s disease: a systematic review and meta-analysis of the current literature

    Attauabi, M., Burisch, J. & Seidelin, Jakob Benedict, 2021, In: Scandinavian Journal of Gastroenterology. 56, 1, p. 53-58 6 p.

    Research output: Contribution to journalReviewResearchpeer-review

  45. Published

    IBD metabonomics predicts phenotype, disease course, and treatment response

    Bjerrum, Jakob Tveiten , Wang, Y. L., Seidelin, Jakob Benedict & Nielsen, Ole Haagen, 2021, In: EBioMedicine. 71, 103551.

    Research output: Contribution to journalReviewResearchpeer-review

  46. Published

    Prevalence and outcomes of COVID-19 among patients with inflammatory bowel disease: A Danish prospective population-based cohort study

    Attauabi, M., Poulsen, A., Theede, K., Pedersen, N., Larsen, L., Jess, T., Rosager Hansen, M., Kajbæk Verner-Andersen, M., V Haderslev, K., Berg Lødrup, A., Molazahi, A., Neumann, A., Wase, A., Seidelin, Jakob Benedict & Burisch, J., 2021, In: Journal of Crohn's and Colitis. 15, 4, p. 540–550

    Research output: Contribution to journalJournal articleResearchpeer-review

  47. Published

    Short and long-term effectiveness and safety of vedolizumab in treatment-refractory patients with ulcerative colitis and Crohn's disease - a real-world two-center cohort study

    Attauabi, M., Vind, Ida, Pedersen, G., Bendtsen, Flemming, Seidelin, Jakob Benedict & Burisch, J., 2021, In: European journal of gastroenterology & hepatology. 33, 15, p. 709-718

    Research output: Contribution to journalJournal articleResearchpeer-review

  48. Published

    The Incidence and Disease Course of Perianal Crohn's Disease: A Danish Nationwide Cohort Study, 1997-2015

    Wewer, M. D., Zhao, M., Nordholm-Carstensen, A., Weimers, P., Seidelin, Jakob Benedict & Burisch, J., 2021, In: Journal of Crohn's and Colitis (JCC). 15, 1, p. 5-13

    Research output: Contribution to journalJournal articleResearchpeer-review

  49. Published

    Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases

    Attauabi, M., Höglund, C., Fassov, J., Pedersen, K. B., Hansen, H. B., Wildt, S., Jensen, M. D., Neumann, A., Lind, C., Jacobsen, H. A., Popa, A. M., Kjeldsen, J., Pedersen, N., Molazahi, A., Haderslev, K., Aalykke, C., Knudsen, T., Cebula, W., Munkholm, P., Bendtsen, F. & 2 others, Seidelin, Jakob Benedict & Burisch, J., 2021, In: Scandinavian Journal of Gastroenterology. 56, 9, p. 1040-1048

    Research output: Contribution to journalJournal articleResearchpeer-review

  50. 2020
  51. Published

    A fully defined 3D matrix for ex vivo expansion of human colonic organoids from biopsy tissue

    Bergenheim, F., Fregni, G., Buchanan, C. F., Riis, Lene Buhl, Heulot, M., Touati, J., Seidelin, Jakob Benedict, Rizzi, S. C. & Nielsen, Ole Haagen, 2020, In: Biomaterials. 262, 11 p., 120248.

    Research output: Contribution to journalJournal articleResearchpeer-review

  52. Published

    Crohn's disease with progressive renal impairment

    Seidelin, Jakob Benedict, Riis, Lene Buhl & Butt, Rizwan Ahmed, 2020, In: Gastroenterology. 158, 1, p. 58-59 2 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  53. Published

    Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy - The Danish IBD Biobank Project: protocol for a multicentre prospective cohort study

    Zhao, M., Bendtsen, Flemming, Petersen, Andreas Munk, Larsen, L., Dige, A., Hvas, C., Seidelin, Jakob Benedict & Burisch, J., 2020, In: BMJ Open. 10, 2, 7 p., e035756.

    Research output: Contribution to journalJournal articleResearchpeer-review

  54. Published

    SMAC mimetics and RIPK inhibitors as therapeutics for chronic inflammatory diseases

    Jensen, S., Seidelin, Jakob Benedict, LaCasse, E. C. & Nielsen, Ole Haagen, 2020, In: Science Signaling. 13, 619, 18 p., eaax8295.

    Research output: Contribution to journalReviewResearchpeer-review

  55. 2019
  56. Published

    Exposome and Diet

    Seidelin, Jakob Benedict & Burisch, J., 2019, Biomarkers in Inflammatory Bowel Diseases. Sheng Ding, N. & De Cruz, P. (eds.). Springer, p. 281-291 Chapter 23

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

Previous 1 2 3 Next

ID: 33971112